2017 Fiscal Year Final Research Report
The new therapy of loss of pregnancy ~ Endothelial progenitor cells for vascular medicine and recombinant human soluble thrombomodulin
| Project/Area Number |
15K20168
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Obstetrics and gynecology
|
|---|
| Research Institution | Osaka Medical College |
|---|
Principal Investigator |
|
|---|
| Research Collaborator |
SANO Takumi 大阪医科大学, 医学部, 助教 (30817185)
|
|---|
| Project Period (FY) |
2015-04-01 – 2018-03-31
|
| Keywords | 不育症 / 遺伝子組換え型ヒトトロンボモジュリン製剤 / リコモジュリン / 抗凝固療法 / sFlt-1 / preeclampsia / 妊娠高血圧腎症 / 習慣性流産 |
|---|
| Outline of Final Research Achievements |
Recombinant human Thrombomodulin(r-TM) as an anticoagulation therapy has the potential for the medical treatment of recurrent miscarriage and fetal growth restriction due to improved angiogenic factors. Additionally, r-TM treatment has the potential for the recovery of preeclampsia.
|
| Free Research Field |
周産期、不育症
|
